1
|
Han ZJ, Wu XD, Cheng JJ, Zhao SD, Gao MZ,
Huang HY, Gu B, Ma P, Chen Y, Wang JH, et al: Diagnostic accuracy
of natriuretic peptides for heart failure in patients with pleural
effusion: A systematic review and updated meta-analysis. PLoS One.
10:e01343762015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Johnson KR and Olson KR: Responses of the
trout cardiac natriuretic peptide system to manipulation of salt
and water balance. Am J Physiol Regul Integr Comp Physiol.
296:R1170–R1179. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Brutsaert DL: Cardiac dysfunction in heart
failure: The cardiologist's love affair with time. Prog Cardiovasc
Dis. 49:157–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Stępień-Wałek AM and Wożakowska-Kapłon B:
The effect of left ventricle diastolic function on the secretion of
B-type natriuretic peptide at rest and directly after exercise test
in asymptomatic patients with diabetes or after myocardial
infarction with preserved left ventricular systolic function.
Kardiol Pol. Nov 12–2015.(Epub ahead of print). doi:
10.5603/KP.a2015.0216.
|
5
|
Morita E, Yasue H, Yoshimura M, Ogawa H,
Jougasaki M, Matsumura T, Mukoyama M and Nakao K: Increased plasma
levels of brain natriuretic peptide in patients with acute
myocardial infarction. Circulation. 88:82–91. 1993. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ellulu MS, Patimah I, Khaza'ai H, Rahmat
A, Abed Y and Ali F: Atherosclerotic cardiovascular disease: A
review of initiators and protective factors. Inflammopharmacology.
24:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lin E, Hashimoto B and Hwang W: Imaging of
subclinical atherosclerosis: questions and answers. Curr Probl
Diagn Radiol. 40:116–126. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Clerico A and Emdin M: Diagnostic accuracy
and prognostic relevance of the measurement of cardiac natriuretic
peptides: A review. Clin Chem. 50:33–50. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Doust JA, Glasziou PP, Pietrzak E and
Dobson AJ: A systematic review of the diagnostic accuracy of
natriuretic peptides for heart failure. Arch Intern Med.
164:1978–1984. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Roberts E, Ludman AJ, Dworzynski K,
Al-Mohammad A, Cowie MR, McMurray JJ and Mant J: NICE Guideline
Development Group for Acute Heart Failure: The diagnostic accuracy
of the natriuretic peptides in heart failure: Systematic review and
diagnostic meta-analysis in the acute care setting. BMJ.
350:h9102015. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Clerico A, Fontana M, Zyw L, Passino C and
Emdin M: Comparison of the diagnostic accuracy of brain natriuretic
peptide (BNP) and the N-terminal part of the propeptide of BNP
immunoassays in chronic and acute heart failure: A systematic
review. Clin Chem. 53:813–822. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Szilveszter B, Celeng C and
Maurovich-Horvat P: Plaque assessment by coronary CT. Int J
Cardiovasc Imaging. 32:161–172. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Nakazato R, Otake H, Konishi A, Iwasaki M,
Koo BK, Fukuya H, Shinke T, Hirata K, Leipsic J, Berman DS and Min
JK: Atherosclerotic plaque characterization by CT angiography for
identification of high-risk coronary artery lesions: A comparison
to optical coherence tomography. Eur Heart J Cardiovasc Imaging.
16:373–379. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hoffmann U, Truong QA, Fleg JL, Goehler A,
Gazelle S, Wiviott S, Lee H, Udelson JE and Schoenfeld D: Design of
the rule out myocardial ischemia/infarction using computer assisted
tomography: A multicenter randomized comparative effectiveness
trial of cardiac computed tomography versus alternative triage
strategies in patients with acute chest pain in the emergency
department. Am Heart J. 163:330–338. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Puchner SB, Ferencik M, Maurovich-Horvat
P, Nakano M, Otsuka F, Kauczor HU, Virmani R, Hoffmann U and
Schlett CL: Iterative image reconstruction algorithms in coronary
CT angiography improve the detection of lipid-core plaque - a
comparison with histology. Eur Radiol. 25:15–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Puchner SB, Liu T, Mayrhofer T, Truong QA,
Lee H, Fleg JL, Nagurney JT, Udelson JE, Hoffmann U and Ferencik M:
High-risk plaque detected on coronary CT angiography predicts acute
coronary syndromes independent of significant stenosis in acute
chest pain: Results from the ROMICAT-II trial. J Am Coll Cardiol.
64:684–692. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhou W, Ni Z, Yu Z, Shi B and Wang Q:
Brain natriuretic peptide is related to carotid plaques and
predicts atherosclerosis in pre-dialysis patients with chronic
kidney disease. Eur J Intern Med. 23:539–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hong YJ, Ahn Y, Sim DS, Yoon NS, Yoon HJ,
Kim KH, Park HW, Kim JH, Jeong MH, Cho JG, et al: Relation between
N-terminal pro-B-type natriuretic peptide and coronary plaque
components in patients with acute coronary syndrome: Virtual
histology-intravascular ultrasound analysis. Coron Artery Dis.
20:518–524. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Peng XL, Lin ZP, Zhang RK and Zhang ZW:
B-type natriuretic peptides and subclinical target organ damage in
essential hypertensive patients. Nan Fang Yi Ke Da Xue Xue Bao.
30:2347–2350. 2010.(In Chinese). PubMed/NCBI
|
20
|
Altintas S, Cardinaels EP, Versteylen MO,
Joosen IA, Seifert M, Wildberger JE, Crijns HJ, Nelemans PJ, Van
Dieijen-Visser MP, Mingels AM, et al: Unstable coronary plaque
characteristics are associated with high-sensitivity cardiac
troponin T and N-terminal pro-brain natriuretic peptide. J
Cardiovasc Comput Tomogr. 10:82–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Amsterdam EA, Wenger NK, Brindis RG, Casey
DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF,
Kontos MC, et al: American College of Cardiology; American Heart
Association Task Force on Practice Guidelines; Society for
Cardiovascular Angiography and Interventions; Society of Thoracic
Surgeons; American Association for Clinical Chemistry: 2014 AHA/ACC
Guideline for the Management of Patients with Non-ST-Elevation
Acute Coronary Syndromes: A report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines. J Am Coll Cardiol. 64:e139–e228. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Taylor AJ, Cerqueira M, Hodgson JM, Mark
D, Min J, O'Gara P, Rubin GD, Kramer CM, Berman D, Brown A, et al:
American College of Cardiology Foundation Appropriate Use Criteria
Task Force; Society of Cardiovascular Computed Tomography; American
College of Radiology; American Heart Association; American Society
of Echocardiography; American Society of Nuclear Cardiology; North
American Society for Cardiovascular Imaging; Society for
Cardiovascular Angiography and Interventions; Society for
Cardiovascular Magnetic Resonance:
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use
criteria for cardiac computed tomography. A report of the American
College of Cardiology Foundation Appropriate Use Criteria Task
Force, the Society of Cardiovascular Computed Tomography, the
American College of Radiology, the American Heart Association, the
American Society of Echocardiography, the American Society of
Nuclear Cardiology, the North American Society for Cardiovascular
Imaging, the Society for Cardiovascular Angiography and
Interventions, and the Society for Cardiovascular Magnetic
Resonance. J Am Coll Cardiol. 56:1864–1894. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Abbara S, Arbab-Zadeh A, Callister TQ,
Desai MY, Mamuya W, Thomson L and Weigold WG: SCCT guidelines for
performance of coronary computed tomographic angiography: A report
of the Society of Cardiovascular Computed Tomography Guidelines
Committee. J Cardiovas Comput Tomogr. 3:190–204. 2009. View Article : Google Scholar
|
24
|
Raff GL, Abidov A, Achenbach S, Berman DS,
Boxt LM, Budoff MJ, Cheng V, DeFrance T, Hellinger JC and Karlsberg
RP: Society of Cardiovascular Computed Tomography: SCCT guidelines
for the interpretation and reporting of coronary computed
tomographic angiography. J Cardiovasc Comput Tomogr. 3:122–136.
2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Austen WG, Edwards JE, Frye RL, Gensini
GG, Gott VL, Griffith LS, McGoon DC, Murphy ML and Roe BB: A
reporting system on patients evaluated for coronary artery disease.
Report of the Ad Hoc Committee for Grading of Coronary Artery
Disease, Council on Cardiovascular Surgery, American Heart
Association. Circulation. 51(Suppl): 5–40. 1975. View Article : Google Scholar : PubMed/NCBI
|
26
|
Agatston AS, Janowitz WR, Hildner FJ,
Zusmer NR, Viamonte M and Detrano R: Quantification of coronary
artery calcium using ultrafast computed tomography. J Am Coll
Cardiol. 15:827–832. 1990. View Article : Google Scholar : PubMed/NCBI
|
27
|
Luscher TF: Substrates of acute coronary
syndromes: new insights into plaque rupture and erosion. Eur Heart
J. 36:1347–1349. 2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Turer AT, Lewis GD, O'Sullivan JF,
Elmariah S, Mega JL, Addo TA, Sabatine MS, de Lemos JA and Gerszten
RE: Increases in myocardial workload induced by rapid atrial pacing
trigger alterations in global metabolism. PLoS One. 9:e990582014.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Sabatine MS, Liu E, Morrow DA, Heller E,
McCarroll R, Wiegand R, Berriz GF, Roth FP and Gerszten RE:
Metabolomic identification of novel biomarkers of myocardial
ischemia. Circulation. 112:3868–3875. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Turer AT, Stevens RD, Bain JR, Muehlbauer
MJ, van der Westhuizen J, Mathew JP, Schwinn DA, Glower DD, Newgard
CB and Podgoreanu MV: Metabolomic profiling reveals distinct
patterns of myocardial substrate use in humans with coronary artery
disease or left ventricular dysfunction during surgical
ischemia/reperfusion. Circulation. 119:1736–1746. 2009. View Article : Google Scholar : PubMed/NCBI
|
31
|
Lewis GD, Wei R, Liu E, Yang E, Shi X,
Martinovic M, Farrell L, Asnani A, Cyrille M, Ramanathan A, et al:
Metabolite profiling of blood from individuals undergoing planned
myocardial infarction reveals early markers of myocardial injury. J
Clin Invest. 118:3503–3512. 2008. View Article : Google Scholar : PubMed/NCBI
|
32
|
Scardovi AB: Associazione Nazionale Medici
Cardiologi Ospedalieri; Società Italiana di Cardiologia Pediatrica;
Società Italiana di Nefrologia Pediatrica; Società Italiana
dell'Ipertensione Arteriosa; Società Italiana di Pediatria:
Clinical applications of brain natriuretic peptide testing. Ital
Heart J Suppl. 5:343–356. 2004.(In Italian). PubMed/NCBI
|
33
|
Meune C, Fulla Y, Martins E, Bergmann JF
and Devaux JY: B-type natriuretic peptide for the diagnostic and
prognostic assessment in cardiology. Its interest and perspectives
of application. Presse Med. 32:181–185. 2003.(In French).
PubMed/NCBI
|
34
|
Clerico A, Recchia FA, Passino C and Emdin
M: Cardiac endocrine function is an essential component of the
homeostatic regulation network: Physiological and clinical
implications. Am J Physiology Heart Circ Physiol. 290:H17–H29.
2006. View Article : Google Scholar
|
35
|
Mazzone M, Forte P, Portale G, Mancini F,
Ursella S, La Sala M, Testa A, Covino M, Pignataro G and Gentiloni
Silveri N: Brain natriuretic peptide and acute coronary syndrome.
Minerva Med. 96:11–18. 2005.PubMed/NCBI
|
36
|
McCullough PA, Peacock WF, O'Neil B, de
Lemos JA, Lepor NE and Berkowitz R: An evidence-based algorithm for
the use of B-type natriuretic testing in acute coronary syndromes.
Rev Cardiovasc Med 11 Suppl. 2:S51–S65. 2010.
|
37
|
Sun C, Zhi J, Bai X, Li X and Xia H:
Comparison of the efficacy of recombinant human brain natriuretic
peptide with saline hydration in preventing contrast-induced
nephropathy in patients undergoing coronary angiography with or
without concomitant percutaneous coronary intervention. Int J Clin
Exp Med. 8:14166–14172. 2015.PubMed/NCBI
|
38
|
Zürcher S, Honegger U, Wagener M, Lee G,
Stallone F, Marxer T, Puelacher C, Schumacher C, Sou SM, Twerenbold
R, et al: Delayed release of brain natriuretic peptide to identify
myocardial ischaemia. Eur J Clin Invest. 45:1175–1183. 2015.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Sun Z and Xu L: Coronary CT angiography in
the quantitative assessment of coronary plaques. Biomed Res Int.
2014:3463802014.PubMed/NCBI
|
40
|
Obaid DR, Calvert PA, Gopalan D, Parker
RA, West NE, Goddard M, Rudd JH and Bennett MR: Dual-energy
computed tomography imaging to determine atherosclerotic plaque
composition: A prospective study with tissue validation. J
Cardiovasc Comput Tomogr. 8:230–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
41
|
Radwan H, Selem A and Ghazal K: Value of
N-terminal pro brain natriuretic peptide in predicting prognosis
and severity of coronary artery disease in acute coronary syndrome.
J Saudi Heart Assoc. 26:192–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
42
|
James SK, Lindahl B, Siegbahn A,
Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol
EJ, Simoons ML and Wallentin L: N-terminal pro-brain natriuretic
peptide and other risk markers for the separate prediction of
mortality and subsequent myocardial infarction in patients with
unstable coronary artery disease: A Global Utilization of
Strategies To Open occluded arteries (GUSTO)-IV substudy.
Circulation. 108:275–281. 2003. View Article : Google Scholar : PubMed/NCBI
|
43
|
Hong YJ, Ahn Y, Sim DS, Yoon NS, Yoon HJ,
Kim KH, Park HW, Kim JH, Jeong MH, Cho JG, et al: Relation between
N-terminal pro-B-type natriuretic peptide and coronary plaque
components in patients with acute coronary syndrome: virtual
histology-intravascular ultrasound analysis. Coron Artery Dis.
20:518–524. 2009. View Article : Google Scholar : PubMed/NCBI
|
44
|
Beaufrere H, Nevarez JG, Holder K, Pariaut
R, Tully TN and Wakamatsu N: Characterization and classification of
psittacine atherosclerotic lesions by histopathology, digital image
analysis, transmission and scanning electron microscopy. Avian
Pathol. 40:531–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
45
|
Stary HC, Chandler AB, Dinsmore RE, Fuster
V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD and
Wissler RW: A definition of advanced types of atherosclerotic
lesions and a histological classification of atherosclerosis. A
report from the Committee on Vascular Lesions of the Council on
Arteriosclerosis, American Heart Association. Circulation.
92:1355–1374. 1995. View Article : Google Scholar : PubMed/NCBI
|
46
|
Saremi F and Achenbach S: Coronary plaque
characterization using CT. AJR Am J Roentgenol. 204:W249–W260.
2015. View Article : Google Scholar : PubMed/NCBI
|
47
|
Salama RH, El-Moniem AE, El-Hefney N and
Samor T: N-Terminal PRO-BNP in acute coronary syndrome patients
with ST elevation versus non ST elevation in Qassim region of Saudi
Arabia. Int J Health Sci (Qassim). 5:136–145. 2011.PubMed/NCBI
|
48
|
Maurovich-Horvat P, Ferencik M, Voros S,
Merkely B and Hoffmann U: Comprehensive plaque assessment by
coronary CT angiography. Nat Rev Cardiol. 11:390–402. 2014.
View Article : Google Scholar : PubMed/NCBI
|
49
|
Min JK, Lin FY, Dunning AM, Delago A, Egan
J, Shaw LJ, Berman DS and Callister TQ: Incremental prognostic
significance of left ventricular dysfunction to coronary artery
disease detection by 64-detector row coronary computed tomographic
angiography for the prediction of all-cause mortality: results from
a two-centre study of 5330 patients. Eur Heart J. 31:1212–1219.
2010. View Article : Google Scholar : PubMed/NCBI
|
50
|
Sozzi FB, Civaia F, Rossi P, Robillon JF,
Rusek S, Berthier F, Bourlon F, Iacuzio L, Dreyfus G and Dor V:
Long-term follow-up of patients with first-time chest pain having
64-slice computed tomography. Am J Cardiol. 107:516–521. 2011.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Shmilovich H, Cheng VY, Tamarappoo BK, Dey
D, Nakazato R, Gransar H, Thomson LE, Hayes SW, Friedman JD,
Germano G, et al: Vulnerable plaque features on coronary CT
angiography as markers of inducible regional myocardial
hypoperfusion from severe coronary artery stenoses.
Atherosclerosis. 219:588–595. 2011. View Article : Google Scholar : PubMed/NCBI
|
52
|
Schlett CL, Nance JW Jr, Schoepf UJ,
O'Brien TX, Ebersberger U, Headden GF, Hoffman U and Bamberg F:
Differences in coronary artery disease by CT angiography between
patients developing unstable angina pectoris vs. major adverse
cardiac events. Eur J Radiol. 83:1113–1119. 2014. View Article : Google Scholar : PubMed/NCBI
|
53
|
Chow BJ, Wells GA, Chen L, Yam Y,
Galiwango P, Abraham A, Sheth T, Dennie C, Beanlands RS and Ruddy
TD: Prognostic value of 64-slice cardiac computed tomography
severity of coronary artery disease, coronary atherosclerosis, and
left ventricular ejection fraction. J Am Coll Cardiol.
55:1017–1028. 2010. View Article : Google Scholar : PubMed/NCBI
|
54
|
Palazzuoli A, Gennari L, Calabria P,
Quatrini I, Vecchiato L, De Paola V, Campagna MS, Palazzuoli V and
Nuti R: Relation of plasma brain natriuretic peptide levels in
non-ST-elevation coronary disease and preserved systolic function
to number of narrowed coronary arteries. Am J Cardiol.
96:1705–1710. 2005. View Article : Google Scholar : PubMed/NCBI
|
55
|
Sadanandan S, Cannon CP, Chekuri K, Murphy
SA, Dibattiste PM, Morrow DA, de Lemos JA, Braunwald E and Gibson
CM: Association of elevated B-type natriuretic peptide levels with
angiographic findings among patients with unstable angina and
non-ST-segment elevation myocardial infarction. J Am Coll Cardiol.
44:564–568. 2004. View Article : Google Scholar : PubMed/NCBI
|
56
|
Weber M, Dill T, Arnold R, Rau M, Ekinci
O, Müller KD, Berkovitsch A, Mitrovic V and Hamm C: N-terminal
B-type natriuretic peptide predicts extent of coronary artery
disease and ischemia in patients with stable angina pectoris. Am
Heart J. 148:612–620. 2004. View Article : Google Scholar : PubMed/NCBI
|
57
|
Liu B, Fu Q, Yan QN, Jin W, Tao DP, Hua JH
and Li ZL: Value of biochemical marker detection in risk
stratification in patients with acute coronary syndrome. Nan Fang
Yi Ke Da Xue Xue Bao. 30:1015–1019. 2010.PubMed/NCBI
|
58
|
Lewandrowski K, Chen A and Januzzi J:
Cardiac markers for myocardial infarction. A brief review. Am J
Clin Pathology. 118(Suppl): S93–S99. 2002.
|
59
|
Clerico A, Prontera C, Emdin M, Passino C,
Storti S, Poletti R, Zyw L and Zucchelli GC: Analytical performance
and diagnostic accuracy of immunometric assays for the measurement
of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP.
Clin Chem. 51:445–447. 2005. View Article : Google Scholar : PubMed/NCBI
|
60
|
Apple FS, Panteghini M, Ravkilde J, Mair
J, Wu AH, Tate J, Pagani F, Christenson RH and Jaffe AS: Committee
on Standardization of Markers of Cardiac Damage of the IFCC:
Quality specifications for B-type natriuretic peptide assays. Clin
Chem. 51:486–493. 2005. View Article : Google Scholar : PubMed/NCBI
|
61
|
Dey D, Achenbach S, Schuhbaeck A,
Pflederer T, Nakazato R, Slomka PJ, Berman DS and Marwan M:
Comparison of quantitative atherosclerotic plaque burden from
coronary CT angiography in patients with first acute coronary
syndrome and stable coronary artery disease. J Cardiovasc Comput
Tomogr. 8:368–374. View Article : Google Scholar : PubMed/NCBI
|
62
|
Toutouzas K, Stathogiannis K, Synetos A,
Karanasos A and Stefanadis C: Vulnerable atherosclerotic plaque:
From the basic research laboratory to the clinic. Cardiology.
123:248–253. 2012. View Article : Google Scholar : PubMed/NCBI
|
63
|
Larsen AI, Nilsen DW, Yu J, Mehran R,
Nikolsky E, Lansky AJ, Caixeta A, Parise H, Fahy M, Cristea E, et
al: Long-term prognosis of patients presenting with ST-segment
elevation myocardial infarction with no significant coronary artery
disease (from the HORIZONS-AMI trial). Am J Cardiol. 111:643–648.
2013. View Article : Google Scholar : PubMed/NCBI
|